Preclinical evaluation of cell-based strategies to prevent or treat bronchopulmonary dysplasia in animal models: a systematic review

References

• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A systematic analysis and implications. Lancet 2012;379:2162–72.
   PubMed Web of Science ®Google Scholar
• Liu L, Johnson HL, Cousens S, Child Health Epidemiology Reference Group of WHO, Unicef, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012;379:2151–61.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261–9.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Greenough A, Abman SH. Bronchopulmo-nary dysplasia. Lancet 2006;367:1421–31.
   PubMed Web of Science ®Google Scholar
• Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res Part A Clin Mol Teratol 2014;100:145–57.
   PubMed Web of Science ®Google Scholar
• Carlo WA, McDonald SA, Fanaroff AA, et al. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks’ gestation. JAMA 2011;306:2348–58.
   PubMed Web of Science ®Google Scholar
• Jobe AH. What is BPD in 2012 and what will BPD become? Early Human Dev 2012;88:S27–8.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Internal Med 2009;151:264–9.
   PubMed Web of Science ®Google Scholar
• MR M, Collaborative Approach to Meta Analysis and Review of Animal Data from Experimental Studies (CAMARADES); 2011.
   Google Scholar
• Hodges RJ, Jenkin G, Hooper SB, et al. Human amnion epithelial cells reduce ventilation-induced preterm lung injury in fetal sheep. Am J Obst Gynecol 2012;206:448.e8–15.
   PubMed Web of Science ®Google Scholar
• Pierro M, Ionescu L, Montemurro T, et al. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2013;68:475–84.
   PubMed Web of Science ®Google Scholar
• Chang YS, Choi SJ, Ahn SY, et al. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS One 2013;8:e52419.
   Web of Science ®Google Scholar
• Guillot PV, Gotherstrom C, Chan J, et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007;25:646–54.
   PubMed Web of Science ®Google Scholar
• Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regener Med 2014;9:27–39.
   PubMed Web of Science ®Google Scholar
• Sammour I, Somashekar S, Huang J, et al. The effect of gender on mesenchymal stem cell (MSC) efficacy in neonatal hyperoxia-induced lung injury. PLoS One 2016;11:e0164269.
   PubMed Web of Science ®Google Scholar
• Healy AM, Morgenthau L, Zhu X, et al. VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung. Dev Dyn: Off Publ Am Assoc Anatom 2000;219:341–52.
   PubMed Web of Science ®Google Scholar
• Bhatt AJ, Pryhuber GS, Huyck H, et al. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respirat Crit Care Med 2001;164:1971–80.
   PubMed Web of Science ®Google Scholar
• Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477–86.
   PubMed Web of Science ®Google Scholar
• Chang YS, Ahn SY, Jeon HB, et al. Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol 2014;51:391–9.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Chang YS, Kim SY, et al. Long-term (postnatal day 70) outcome and safe of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury. Yonsei Med J 2013;54:416–24.
   PubMed Web of Science ®Google Scholar
• Ahn SY, Chang YS, Sung DK, et al. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy 2015;17:1025–35.
   PubMed Web of Science ®Google Scholar
• Chang YS, Choi SJ, Sung DK, et al. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2011;20:1843–54.
   PubMed Web of Science ®Google Scholar
• Chang YS, Oh W, Choi SJ, et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 2009;18:869–86.
   PubMed Web of Science ®Google Scholar
• Chang YS, Ahn SY, Yoo HS, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr 2014;164:966–72 e6.
   PubMed Web of Science ®Google Scholar
• Tropea KA, Leder E, Aslam M, et al. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J of Physiol Lung Cell Mol Physiol 2012;302:L829–37.
   PubMed Web of Science ®Google Scholar
• Aslam M, Baveja R, Liang OD, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respirat Crit Care Med 2009;180:1122–30.
   PubMed Web of Science ®Google Scholar
• Luan Y, Ding W, Ju ZY, et al. Bone marrow-derived mesenchymal stem cells protect against lung injury in a mouse model of bronchopulmonary dysplasia. Mol Med Rep 2015;11:1945–50.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Pan YY, Jing RS, et al. Protective effects of BMSCs in combination with erythropoietin in bronchopulmonary dysplasia-induced lung injury. Mol Med Rep 2016;14:1302–8.
   PubMed Web of Science ®Google Scholar
• Luan Y, Zhang L, Chao S, Liu X, Li K, Wang Y, Zhang Z. Mesenchymal stem cells in combination with erythropoietin repair hyperoxia-induced alveoli dysplasia injury in neonatal mice via inhibition of TGF-beta1 signaling. Oncotarget 2016;7:47082–94.
   PubMed Web of Science ®Google Scholar
• Fritzell JA, Jr, Mao Q, Gundavarapu S, et al. Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol 2009;40:575–87.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Wang H, Shi Y, et al. Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 2012;36:589–94.
   PubMed Web of Science ®Google Scholar
• Vosdoganes P, Lim R, Koulaeva E, et al. Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice. Cytotherapy 2013;15:1021–9.
   PubMed Web of Science ®Google Scholar
• Zhu DD, Muljadi R, Chan ST, et al. Evaluating the impact of human amnion epithelial cells on angiogenesis. Stem Cells Int 2016;2016:4565612.
   PubMed Web of Science ®Google Scholar
• Liu LS, Mao QF, Chu S, et al. Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury. Am J Pathol 2014;184:3344–58.
   PubMed Web of Science ®Google Scholar
• Monz D, Tutdibi E, Mildau C, et al. Human umbilical cord blood mononuclear cells in a double-hit model of bronchopulmonary dysplasia in neonatal mice. PLoS One 2013;8:e74740.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam V, Ryan SL, Seedorf GJ, et al. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol-Lung Cell Mol Physiol 2010;298:L315–23.
   PubMed Web of Science ®Google Scholar
• Alphonse RS, Vadivel A, Fung M, et al. Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth. Circulation 2014;129:2144.
   PubMed Web of Science ®Google Scholar
• De Paepe ME, Mao QF, Chu SR, Padbury JF. Long-term outcome of human cord blood-derived hematopoietic progenitor cells in murine lungs. Exp Lung Res 2013;39:59–69.
   PubMed Web of Science ®Google Scholar
• Mao Q, Chu S, Ghanta S, et al. Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs. Respirat Res 2013;14:37.
   PubMed Web of Science ®Google Scholar
• Yao L, Liu CJ, Luo Q, et al. Protection against hyperoxia-induced lung fibrosis by KGF-induced MSCs mobilization in neonatal rats. Pediatric Transplant 2013;17:676–82.
   PubMed Web of Science ®Google Scholar
• Zhang HS, Fang JP, Su HB, et al. Bone marrow mesenchymal stem cells attenuate lung inflammation of hyperoxic newborn rats. Pediatric Transplant 2012;16:589–98.
   PubMed Web of Science ®Google Scholar
• Zhang HS, Fang JP, Wu YY, et al. Mesenchymal stem cells protect against neonatal rat hyperoxic lung injury. Expert Opin Biol Therapy 2013;13:817–29.
   PubMed Web of Science ®Google Scholar
• Van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respirat Critical Care Med 2009;180:1131–42.
   PubMed Web of Science ®Google Scholar
• Gulasi S, Atici A, Yilmaz SN, et al. Mesenchymal stem cell treatment in hyperoxia-induced lung injury in newborn rats. Pediatr Int 2016;58:206–13.
   PubMed Web of Science ®Google Scholar
• Sutsko RR, Young KC, Ribeiro A, et al. Long-term reparative effects of mesenchymal stem cell therapy following neonatal hyperoxia-induced lung injury. Pediatric Res 2013;73:46–53.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Suguihara C, Drummond S, et al. Bone marrow-derived c-kit(+) cells attenuate neonatal hyperoxia-induced lung injury. Cell Transplant 2015;24:85–95.
   PubMed Web of Science ®Google Scholar
• Tian ZF, Li YH, Ji P, et al. Mesenchymal stem cells protects hyperoxia-induced lung injury in newborn rats via inhibiting receptor for advanced glycation end-products/nuclear factor kappa B signaling. Exp Biol Med 2013;238:242–7.
   Web of Science ®Google Scholar
• Kim YE, Park WS, Sung DK, et al. Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats. Pediatr Res 2016;80:415–24.
   PubMed Web of Science ®Google Scholar
• Sung DK, Chang YS, Ahn SY, et al. Optimal route for human umbilical cord blood-derived mesenchymal stem cell transplantation to protect against neonatal hyperoxic lung injury: gene expression profiles and histopathology. PLoS One 2015;10:e0135574.
   PubMed Web of Science ®Google Scholar
• Grisafi D, Pozzobon M, Dedja A, et al. Human amniotic fluid stem cells protect rat lungs exposed to moderate hyperoxia. Pediatric Pulmonol 2013;48:1070–80.
   PubMed Web of Science ®Google Scholar
• Lu AZ, Sun B, Qian LL. Combined iNO and endothelial progenitor cells improve lung alveolar and vascular structure in neonatal rats exposed to prolonged hyperoxia. Pediatric Res 2015;77:784–92.
   PubMed Web of Science ®Google Scholar
• Chou HC, Li YT, Chen CM. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Am J Transl Res 2016;8:342–53.
   PubMed Web of Science ®Google Scholar
• Hansmann G, Fernandez-Gonzalez A, Aslam M, et al. Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulmonary Circ 2012;2:170–81.
   PubMedGoogle Scholar
• Waszak P, Alphonse R, Vadivel A, et al. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells Dev 2012;21:2789–97.
   PubMed Web of Science ®Google Scholar